High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients
Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This prospective, non-randomized, non-controlled clinical trial was conducted to examine the
clinical outcomes achieved by using initial high-dose intravitreal ganciclovir injections of
ganciclovir in treating cytomegalovirus (CMV) retinitis in patients without human
immunodeficiency virus (HIV) infection.
Phase:
N/A
Details
Lead Sponsor:
Aier School of Ophthalmology, Central South University